Cincinnati Bell Inc. (NYSE: CBB) today announced that Chris Elma, vice
president treasury and tax of Cincinnati Bell Inc., will be presenting
at the Bank of America Merrill Lynch Leveraged Finance Conference on
Tuesday, December 2, 2014 at 10:10 a.m. EST.
Cincinnati Bell Inc. (NYSE: CBB) today announced that Josh Duckworth,
vice president investor relations of Cincinnati Bell Inc., will be
presenting at the Wells Fargo Securities Technology, Media & Telecom
Conference on Thursday, November 13, 2014 at 3:15 p.m. EST.
By Andria Cheng, MarketWatch
NEW YORK (MarketWatch) -- Whole Foods Market Inc. recently unveiled its first national brand campaign, with a "Values Matter" tag line to show why it's "America's healthiest grocery store." Whether that message can boost sales will be a focus when the largest U.S. organic and natural grocer reports its fiscal fourth-quarter earnings after close of regular trading on Wednesday.
Trinity Industries, Inc. (NYSE:TRN) announced today that its subsidiary,
Trinity Rail Group, LLC, has entered into a supply agreement with GATX
Corporation (“GATX”) to deliver 8,950 railcars over a four-year period,
beginning March 2016.
By Rex Crum, MarketWatch
SAN FRANCISCO (MarketWatch) -- Tech stocks started November's trading with broad gains Monday, led by advances from the likes of Apple Inc. and GoPro Inc.
Apple (AAPL) continued its recent strong performance, rising 1.3% to an all-time high close of $109.40 a share.
Sign-up for Aviv REIT INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Aviv REIT Inc. Regarding the Fairness of the Sale of the Company to Omega Healthcare Investors Inc. -- AVIV investment picks
Nuveen Investments, a leading global provider of investment services to
institutions as well as individual investors, today announced that 73 Nuveen
closed-end funds declared regular monthly distributions.
Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical
company focused on developing and commercializing first-in-class, oral
low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies
for the treatment of hypercholesterolemia and other cardiometabolic risk
markers, today announced it will host a conference call and webcast to
report operational and financial results for the third quarter 2014.
PALATINE, IL--(Marketwired - November 03, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse, announced today financial results for the three and nine months ended September 30, 2014.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.